JPH0733633A - External preparation for skin - Google Patents
External preparation for skinInfo
- Publication number
- JPH0733633A JPH0733633A JP18023493A JP18023493A JPH0733633A JP H0733633 A JPH0733633 A JP H0733633A JP 18023493 A JP18023493 A JP 18023493A JP 18023493 A JP18023493 A JP 18023493A JP H0733633 A JPH0733633 A JP H0733633A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- skin
- carbon atoms
- branched
- external preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は皮膚外用剤、更に詳しく
は、角質層の水分保持力を高め、肌あれを改善すること
のできる皮膚外用剤に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a skin external preparation, and more particularly to a skin external preparation capable of enhancing the water-retaining power of the stratum corneum and improving rough skin.
【0002】[0002]
【従来の技術】従来、肌にうるおいを与え、肌を柔軟に
するには、角質層の水分が重要であることが知られてい
る。そして、当該水分の保持は、角質層に含まれている
水溶性成分、すなわち遊離アミノ酸、有機酸、尿素又は
無機イオンによるものであるとされ、これらの物質は単
独であるいは組み合わせて薬用皮膚外用剤あるいは化粧
料に配合して、肌あれの改善又は予防の目的で使用され
ている。2. Description of the Related Art Conventionally, it has been known that the water content of the stratum corneum is important for moisturizing and softening the skin. The retention of the water is said to be due to a water-soluble component contained in the stratum corneum, that is, a free amino acid, an organic acid, urea or an inorganic ion, and these substances are used alone or in combination, and a medicated skin external preparation. Alternatively, it is used in cosmetics for the purpose of improving or preventing skin roughness.
【0003】また、これとは別に水と親和性が高い多く
の保湿性物質が開発され、同様の目的で使用されてい
る。Apart from this, many moisturizing substances having a high affinity with water have been developed and used for the same purpose.
【0004】更に、近年では、角質細胞間に存在する脂
質が高い保湿能を有することが見出され、当該角質細胞
間脂質成分の類似構造物質で構成される人工細胞間脂質
によって、肌にうるおいを与え、柔軟化させることが行
われ、比較的高い効果が得られている。Furthermore, in recent years, it has been found that lipids existing between keratinocytes have a high moisturizing ability, and the artificial intercellular lipids composed of the structurally similar substances of the interkeratinocyte lipid component moisturize the skin. Is given and is made flexible, and a relatively high effect is obtained.
【0005】[0005]
【発明が解決しようとする課題】しかしながら、角質層
内に存在する水溶性成分等の保湿性物質を皮膚に適用し
た場合、その作用は、皮膚角質上にあって水分を角質に
供給するというもので、しかもその効果は一時的であ
り、根本的に角質層の水分保持能力を改善し、肌あれを
本質的に予防あるいは治癒させるというものではなかっ
た。However, when a moisturizing substance such as a water-soluble component present in the stratum corneum is applied to the skin, its action is to provide water to the stratum corneum and supply water to the stratum corneum. However, the effect was temporary, and it was not intended to fundamentally improve the water-retaining ability of the stratum corneum and essentially prevent or cure the rough skin.
【0006】また、人工細胞間脂質を皮膚に適用した場
合には、角質層の水分保持能を根本的に改善し、肌あれ
の予防あるいは治癒させる効果をある程度得ることはで
きるが、完全に生体と等しいレベルまでには至ってはお
らず、未だ満足し得るものではなかった。When artificial intercellular lipids are applied to the skin, the water-retaining ability of the stratum corneum can be fundamentally improved, and the effect of preventing or healing skin roughening can be obtained to some extent, but it is completely effective in living organisms. It has not reached the level equal to and was not yet satisfactory.
【0007】従って、角質層の水分保持能力を根本的に
改善し、荒れた角質層を生体健常と同等のレベルまでに
機能回復させることができ、肌にうるおい感と柔軟性と
を付与する皮膚外用剤の開発が望まれていた。[0007] Therefore, it is possible to fundamentally improve the water-retaining ability of the stratum corneum and restore the function of the rough stratum corneum to a level equivalent to that of a healthy body, and to give the skin a feeling of moisture and flexibility. Development of an external preparation has been desired.
【0008】[0008]
【課題を解決するための手段】斯かる実情において、本
発明者らは上記問題点を解決すべく角質細胞間脂質分子
同士の相互作用に注目して鋭意研究を行ったところ、後
記一般式(1)で表わされるセラミド及び/又は後記一
般式(2)で表わされるセラミドの類似構造物質と後記
一般式(3)で表わされる化合物とを組み合わせて含有
させることにより、セラミド及び/又はセラミド類似構
造物質を液晶状に配向させることができ、安定でしかも
上記課題を解決した皮膚外用剤が得られることを見出
し、本発明を完成した。Under these circumstances, the present inventors have conducted diligent research focusing on the interaction between lipid molecules between keratinocytes in order to solve the above-mentioned problems. A ceramide and / or a ceramide-like structure containing a ceramide represented by 1) and / or a ceramide-like structural substance represented by the following general formula (2) in combination with a compound represented by the following general formula (3) The present invention has been completed by finding that a substance can be aligned in a liquid crystal state and that a stable external preparation for skin can be obtained.
【0009】すなわち、本発明は、次の成分(A)及び
(B): (A)一般式(1)That is, the present invention provides the following components (A) and (B): (A) General formula (1)
【0010】[0010]
【化4】 [Chemical 4]
【0011】(式中、R1 及びR2 は1個以上の水酸基
が置換することのある炭素数8〜26の直鎖若しくは分
岐鎖の飽和若しくは不飽和の炭化水素基を示す)で表わ
されるセラミド及び一般式(2)(Wherein R 1 and R 2 represent a linear or branched, saturated or unsaturated hydrocarbon group having 8 to 26 carbon atoms, which may be substituted by one or more hydroxyl groups). Ceramide and general formula (2)
【0012】[0012]
【化5】 [Chemical 5]
【0013】(式中、R3 は炭素数10〜26の直鎖若
しくは分岐鎖の飽和若しくは不飽和の炭化水素基を示
し、R4 は炭素数9〜25の直鎖若しくは分岐鎖の飽和
若しくは不飽和の炭化水素基を示す)で表わされるセラ
ミドの類似構造物質からなる群より選ばれる一種又は二
種以上 (B)一般式(3) R5-(OCH2CH2)n-OH (3) 〔式中、R5 はコレステロール類の水酸基プロトンを除
く残基又は次式(4)(In the formula, R 3 represents a straight chain or branched chain saturated or unsaturated hydrocarbon group having 10 to 26 carbon atoms, and R 4 represents a straight chain or branched chain saturated or unsaturated group having 9 to 25 carbon atoms. 1 or more selected from the group consisting of ceramide-like structural substances represented by (representing an unsaturated hydrocarbon group) (B) General formula (3) R 5- (OCH 2 CH 2 ) n -OH (3 [Wherein R 5 is a residue excluding hydroxyl group protons of cholesterols or the following formula (4)
【0014】[0014]
【化6】 [Chemical 6]
【0015】(式中、R6 は炭素数10〜26の直鎖又
は分岐鎖のアルキレン基を示し、R7及びR8 はそれぞ
れポリオキシエチレンが付加していてもよい炭素数10
〜26の直鎖又は分岐鎖のアルキル基を示す)で表わさ
れる基を示し、nは5〜40の整数を示す〕で表わされ
る化合物を含有する皮膚外用剤を提供するものである。(In the formula, R 6 represents a linear or branched alkylene group having 10 to 26 carbon atoms, and R 7 and R 8 each have 10 carbon atoms to which polyoxyethylene may be added.
The group represented by the formula (1) to (26 represents a straight chain or branched chain alkyl group), and n represents an integer of 5 to 40].
【0016】本発明で用いられる成分(A)のうち、セ
ラミドは前記一般式(1)で示され、これは公知の化合
物である。(1)式中、R1 及びR2 で示される炭素数
8〜26の直鎖又は分岐鎖の飽和又は不飽和の炭化水素
基としては、例えばオクチル、ノニル、デシル、ドデシ
ル、ウンデシル、トリデシル、テトラデシル、ペンタデ
シル、ヘキサデシル、ヘプタデシル、オクタデシル、ノ
ナデシル、エイコシル、ヘンエイコシル、ドコシル、ト
リコシル、テトラコシル、ペンタコシル、ヘキサコシ
ル、ノネニル、デセニル、ドデセニル、ウンデセニル、
トリデセニル、テトラデセニル、ペンタデセニル、ヘキ
サデセニル、ヘプタデセニル、オクタデセニル、ノナデ
セニル、エイコセニル、ヘンエイコセニル、ドコセニ
ル、トリコセニル、テトラコセニル、ペンタコセニル、
ヘキサコセニル、ノナジエニル、デカジエニル、ドデカ
ジエニル、ウンデカジエニル、トリデカジエニル、テト
ラデカジエニル、ペンタデカジエニル、ヘキサデカジエ
ニル、ヘプタデカジエニル、オクタデカジエニル、ノナ
デカジエニル、エイコサジエニル、ヘンエイコサジエニ
ル、ドコサジエニル、トリコサジエニル、テトラコサジ
エニル、ペンタコサジエニル、ヘキサコサジエニル、2
−ヘキシルデシル、2−オクチルウンデシル、2−デシ
ルテトラデシル基等が挙げられる。これらの炭化水素基
は、1個以上の水酸基が置換していてもよい。Of the components (A) used in the present invention, ceramide is represented by the above general formula (1), which is a known compound. In the formula (1), examples of the linear or branched saturated or unsaturated hydrocarbon group having 8 to 26 carbon atoms represented by R 1 and R 2 include octyl, nonyl, decyl, dodecyl, undecyl, tridecyl, Tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, heneicosyl, docosyl, tricosyl, tetracosyl, pentacosyl, hexacosyl, nonenyl, decenyl, dodecenyl, undecenyl,
Tridecenyl, tetradecenyl, pentadecenyl, hexadecenyl, heptadecenyl, octadecenyl, nonadecenyl, eicosenyl, heneicosenyl, docosenyl, tricocenyl, tetracocenyl, pentacocenyl,
Hexacosenyl, nonadienyl, decadienyl, dodecadienyl, undecadienyl, tridecadienyl, tetradecadienyl, pentadecadienyl, hexadecadienyl, heptadecadienyl, octadecadienyl, nonadecadienyl, henecosadienyl, heneicocosadienyl, heneicocosadienyl, heneicosacenyl, Tetracosadienyl, pentacosadienyl, hexacosadienyl, 2
—Hexyldecyl, 2-octylundecyl, 2-decyltetradecyl group and the like. One or more hydroxyl groups may be substituted on these hydrocarbon groups.
【0017】また、成分(A)のうち、前記一般式
(2)で表わされるセラミドの類似構造物質は公知の方
法〔例えば、ポリッシュ・ジャーナル・オブ・ケミスト
リー(Pol.J.Chem.)52,1059(19
78);同52,1283(1978);特開昭54−
117421号公報、同54−144308号公報、同
54−147937号公報、同62−228048号公
報、同63−216852号公報〕に準じて製造するこ
とができる。すなわち、次に示される反応式に従って、
グリシジルエーテルとエタノールアミンから得られる化
合物(5)を脂肪酸メチルエステルと反応させることに
よって製造することができる。Of the component (A), the ceramide-like structural material represented by the general formula (2) can be prepared by a known method [for example, Polish Journal of Chemistry (Pol. J. Chem.) 52 , 1059 (19
78); ibid. 52 , 1283 (1978); JP-A-54-
No. 117421, No. 54-144308, No. 54-147937, No. 62-228048, No. 63-216852]. That is, according to the reaction formula shown below,
It can be produced by reacting a compound (5) obtained from glycidyl ether and ethanolamine with a fatty acid methyl ester.
【0018】[0018]
【化7】 [Chemical 7]
【0019】(式中、R3 及びR4 は前記と同じ意味を
示す) (2)式中、R3 で示される炭素数10〜26の直鎖又
は分岐鎖の飽和又は不飽和の炭化水素基としては、前記
のR1 及びR2 中の炭素数10〜26のものが挙げら
れ、R4 で示される炭素数9〜25の直鎖又は分岐鎖の
飽和又は不飽和の炭化水素基としては、前記のR1 及び
R2 中の炭素数9〜25のものが挙げられる。(Wherein R 3 and R 4 have the same meanings as described above) (2) In the formula, a linear or branched saturated or unsaturated hydrocarbon having 10 to 26 carbon atoms represented by R 3 Examples of the group include those having 10 to 26 carbon atoms in the above R 1 and R 2 , and as a linear or branched saturated or unsaturated hydrocarbon group having 9 to 25 carbon atoms represented by R 4. Are those having 9 to 25 carbon atoms in the above R 1 and R 2 .
【0020】これら成分(A)のセラミド及びセラミド
の類似構造物質は単独で又は二種以上を組み合わせて用
いることができる。These ceramides of the component (A) and substances having a similar structure to ceramides can be used alone or in combination of two or more kinds.
【0021】また、本発明で用いられる成分(B)の化
合物は前記一般式(3)で表わされるものである。
(3)式中、R5 で示されるもののうち、コレステロー
ル類としては、例えばコレステロール、スチグマステロ
ール、β−シトステロール、ラノステロール、エルゴス
テロール等が挙げられる。また、式(4)で表わされる
基において、R7 及びR8 で示される炭素数10〜26
の直鎖又は分岐鎖のアルキル基としては、前記のうちこ
れらに含まれるものが挙げられ、これらのアルキル基は
ポリオキシエチレンが1〜30モル付加していてもよ
い。また、式(3)中、nは5以上40未満の整数を示
す。The compound of the component (B) used in the present invention is represented by the above general formula (3).
Among the compounds represented by R 5 in the formula (3), examples of cholesterols include cholesterol, stigmasterol, β-sitosterol, lanosterol, ergosterol and the like. Further, in the group represented by the formula (4), the number of carbon atoms represented by R 7 and R 8 is 10 to 26.
Examples of the straight chain or branched chain alkyl group include those mentioned above among these, and 1 to 30 mol of polyoxyethylene may be added to these alkyl groups. Further, in the formula (3), n represents an integer of 5 or more and less than 40.
【0022】これらの成分(B)は単独で又は二種以上
を組み合わせて用いることができる。These components (B) can be used alone or in combination of two or more.
【0023】本発明の皮膚外用剤への成分(A)及び成
分(B)の配合比は、重量比で95:5〜5:95、特
に70:30〜20:80であるのが好ましい。これら
を配合するには、両者を上記比率で混合して一旦加熱溶
解後冷却してペースト状としたものを他の成分に添加す
るのが好ましい。The blending ratio of the component (A) and the component (B) to the external preparation for skin of the present invention is preferably 95: 5 to 5:95 by weight, and particularly preferably 70:30 to 20:80. In order to mix these, it is preferable to mix the both in the above proportions, once heat and dissolve, and then cool to form a paste, which is added to the other components.
【0024】成分(A)と成分(B)の混合物の本発明
皮膚外用剤への配合量は、特に制限されないが、通常乳
化型の皮膚外用剤の場合には全組成の0.01〜60重
量%(以下単に%で示す)、特に0.1〜30%が好ま
しく、またスクワラン等の液状炭化水素を基剤とする油
性の皮膚外用剤の場合には1〜90%、特に5〜50%
が好ましい。The amount of the mixture of the components (A) and (B) to be added to the external preparation for skin of the present invention is not particularly limited, but in the case of an emulsified external preparation for skin, 0.01 to 60 of the total composition is usually used. Weight% (hereinafter simply expressed as%), particularly 0.1 to 30% is preferable, and 1 to 90%, particularly 5 to 50 in the case of oily external preparation for skin based on liquid hydrocarbon such as squalane. %
Is preferred.
【0025】また、本発明の皮膚外用剤には、更にグリ
セリンを配合すると液晶が更に安定に維持されるので好
ましい。グリセリンを配合する場合には、グリセリン
と、成分(A)及び成分(B)の混合物との配合比が、
重量比で50:50〜95:5であるのが好ましい。Further, it is preferable that the external preparation for skin of the present invention further contains glycerin because the liquid crystal can be maintained more stably. When blending glycerin, the blending ratio of glycerin and the mixture of component (A) and component (B) is
The weight ratio is preferably 50:50 to 95: 5.
【0026】本発明の皮膚外用剤は、その使用形態にお
いて、薬用皮膚外用剤と化粧料に大別される。The external preparation for skin of the present invention is roughly classified into a medical external preparation for skin and a cosmetic in its use form.
【0027】薬用皮膚外用剤としては、例えば薬効成分
を含有する各種軟膏剤を挙げることができる。軟膏剤と
しては、油性基剤をベースとするもの、油/水、水/油
型の乳化系基剤をベースとするもののいずれであっても
よい。油性基剤としては、特に制限はなく、例えば植物
油、動物油、合成油、脂肪酸及び天然又は合成のグリセ
ライド等が挙げられる。また薬効成分としては、特に制
限はなく、例えば鎮痛消炎剤、鎮痒剤、殺菌消毒剤、収
斂剤、皮膚軟化剤、ホルモン剤等を必要に応じて適宜使
用することができる。Examples of the external medicated skin agent include various ointments containing medicinal components. The ointment may be either an oil-based base, an oil / water, or a water / oil-type emulsion base. The oily base is not particularly limited, and examples thereof include vegetable oil, animal oil, synthetic oil, fatty acid, and natural or synthetic glyceride. In addition, the medicinal component is not particularly limited, and for example, an analgesic / anti-inflammatory agent, an antipruritic agent, a bactericidal disinfectant, an astringent agent, an emollient agent, a hormone agent and the like can be appropriately used as necessary.
【0028】また、化粧料として使用する場合は、必須
成分の他に化粧料成分として一般に使用されている油
分、保湿剤、紫外線吸収剤、アルコール類、キレート
剤、pH調整剤、防腐剤、増粘剤、色素、香料等を任意に
組み合わせて配合することができる。When used as a cosmetic, in addition to the essential ingredients, oils, moisturizers, ultraviolet absorbers, alcohols, chelating agents, pH adjusters, preservatives, and additives commonly used as cosmetic ingredients are used. A sticky agent, a pigment, a fragrance, etc. can be arbitrarily combined and blended.
【0029】化粧料としては、種々の形態、例えば水/
油、油/水型乳化化粧料、クリーム、化粧乳液、化粧
水、油性化粧料、口紅、ファンデーション、皮膚洗浄
剤、ヘアートニック、整髪剤、養毛剤、育毛剤等の皮膚
化粧料とすることができる。As the cosmetics, various forms such as water /
Can be used as skin cosmetics such as oils, oil / water emulsion cosmetics, creams, lotions, lotions, oily cosmetics, lipsticks, foundations, skin cleansers, hair tonics, hair conditioners, hair nourishing agents, hair restorers, etc. .
【0030】[0030]
【作用】本発明皮膚外用剤における、成分(A)と成分
(B)の混合物の作用機構の詳細は完全には解明されて
いないが、成分(A)と成分(B)の組合わせは容易に
多重層ラメラ構造を構築し、その構造体内に多くの束縛
水をもつため、これが角質層の水分保持機能として発揮
されるものと考えられる。The action mechanism of the mixture of the component (A) and the component (B) in the external preparation for skin of the present invention has not been completely clarified, but the combination of the component (A) and the component (B) is easy. Since a multi-layered lamella structure is constructed in the body and a lot of bound water is contained in the structure, it is considered that this is exerted as a water retaining function of the stratum corneum.
【0031】[0031]
【発明の効果】本発明皮膚外用剤は、このような作用を
有する成分(A)と成分(B)の混合物を含有するもの
であるため、肌あれに対して優れた改善及び予防効果を
発揮することができ、しかも外用剤としての保存安定性
が極めて良好である。Since the external preparation for skin of the present invention contains a mixture of the component (A) and the component (B) having such an action, it exerts an excellent effect of improving and preventing skin roughness. The storage stability as an external preparation is extremely good.
【0032】[0032]
【実施例】次に実施例を挙げて本発明を更に説明する
が、本発明はこれらによって何ら限定されるものではな
い。尚、本実施例において、化合物(2a)とは、特開
昭63−192703号公報の参考例1に記載の方法に
従って製造されたN−(2−ヒドロキシ−3−ヘキサデ
シロキシプロピル)−N−2−ヒドロキシエチルヘキサ
デカナミド〔式(2)においてR3 =C16H33、R4 =
C15H31のもの〕を示す。The present invention will be further described with reference to examples, but the present invention is not limited thereto. In this Example, the compound (2a) means N- (2-hydroxy-3-hexadecyloxypropyl) -N produced according to the method described in Reference Example 1 of JP-A-63-192703. 2-hydroxyethylhexadecanamide [in the formula (2), R 3 = C 16 H 33 , R 4 =
C 15 H 31 ] is shown.
【0033】実施例1 成分(A)と成分(B)の混合物の調製:化合物(2
a)を50重量%、ポリオキシエチレンコレステリルエ
ーテル〔式(3)において、R5=コレステロールの水
酸基プロトンを除く残基、n=15のもの〕を50重量
%となるようにガラスネジ口のサンプル瓶に計量する。
サンプル瓶をヒーティング・ブロック等を用いて80℃
となるように加熱する。加熱して完全に溶解したら、全
重量に対して同量の水相を添加攪拌し、空気中で放冷し
てペースト状態の混合物を得る。Example 1 Preparation of Mixture of Component (A) and Component (B): Compound (2
Sample bottle with a glass screw cap so that 50% by weight of a) and 50% by weight of polyoxyethylene cholesteryl ether [in the formula (3), R 5 = residue of cholesterol except hydroxyl protons, n = 15]. Weigh to
Use a heating block to heat the sample bottle to 80 ℃
Heat so that When heated and completely dissolved, the same amount of the aqueous phase is added to the total weight, stirred, and allowed to cool in the air to obtain a mixture in a paste state.
【0034】実施例2 表2に示す組成の皮膚外用剤を製造し、保存安定性、皮
膚コンダクタンス及び肌あれスコアについて評価した。
結果を表3に示す。 (評価方法) (1)保存安定性 皮膚外用剤を−5℃、5℃、室温及び40℃でそれぞれ
1ケ月保存した後、下記の基準により評価した。 ○:相分離が認められず、外観に変化がない。 △:外観には変化がないものの、相分離ないし粘度の変
化が認められる。 ×:相分離が起こり、粘度が著しく変化する。Example 2 A skin external preparation having the composition shown in Table 2 was produced and evaluated for storage stability, skin conductance and skin roughness score.
The results are shown in Table 3. (Evaluation method) (1) Storage stability The external preparation for skin was stored at -5 ° C, 5 ° C, room temperature and 40 ° C for 1 month, and then evaluated according to the following criteria. ◯: No phase separation was observed and there was no change in appearance. Δ: Although there is no change in appearance, phase separation or change in viscosity is observed. X: Phase separation occurs and the viscosity changes significantly.
【0035】(2)皮膚コンダクタンス 冬期に頬部に肌あれを起こしている20〜50才の女性
10名を被験者とし、左右の頬に異なるサンプルを毎日
1回2週間塗布する。2週間の塗布が終了した翌日、3
7℃の温水にて洗顔後、温度20℃、湿度40%の部屋
で20分間安静にした後、角質層の水分含有量を皮膚コ
ンダクタンスメーター(IBS社製)にて測定した。コ
ンダクタンス値は値が小さいほど皮膚は肌あれし、5以
下ではひどい肌あれである。一方この値が20以上であ
れば肌あれはほとんど認められない。(2) Skin Conductance Ten females aged 20 to 50 who have rough skin on the cheeks in winter are used as test subjects, and different samples are applied to the left and right cheeks once a day for 2 weeks. The day after 2 weeks of application, 3
After washing the face with warm water of 7 ° C. and resting in a room at a temperature of 20 ° C. and a humidity of 40% for 20 minutes, the water content of the stratum corneum was measured with a skin conductance meter (manufactured by IBS). The smaller the conductance value is, the rougher the skin is, and when the conductance value is 5 or less, the skin is severely rough. On the other hand, if this value is 20 or more, almost no skin roughness is observed.
【0036】(3)肌あれスコア 皮膚コンダクタンスの場合と同様にサンプルを2週間塗
布した後、肌あれを肉眼で観測し、下記基準により判定
した。スコアは平均値±標準偏差で示した。(3) Skin Roughness Score Similar to the case of skin conductance, the sample was applied for 2 weeks, and then the skin roughness was observed with the naked eye and judged according to the following criteria. The score was shown by the average value +/- standard deviation.
【0037】[0037]
【表1】 [Table 1]
【0038】[0038]
【表2】 [Table 2]
【0039】[0039]
【表3】 [Table 3]
【0040】実施例3 表4に示す組成の皮膚外用剤を製造し、乾燥環境下に1
日放置した後の皮膚外用剤中に含まれる水分量を定量し
た。結果を表4に示す。 (評価方法)皮膚外用剤をシャーレ面に均一に塗布し、
乾燥剤を乾いたデシケータ内に静置した。1日後、皮膚
外用剤中に残留している水分量をカールフィッシャー
(平沼自動水分測定装置 AQV−5)にて定量した。Example 3 An external preparation for the skin having the composition shown in Table 4 was prepared and subjected to 1 in a dry environment.
The amount of water contained in the external preparation for skin after left standing for a day was quantified. The results are shown in Table 4. (Evaluation method) A skin external preparation is evenly applied to the petri dish surface,
The desiccant was left to stand in a desiccator which was dried. One day later, the amount of water remaining in the external preparation for skin was quantified by Karl Fischer (Hiranuma automatic water content measuring device AQV-5).
【0041】[0041]
【表4】 [Table 4]
Claims (3)
とのある炭素数8〜26の直鎖若しくは分岐鎖の飽和若
しくは不飽和の炭化水素基を示す)で表わされるセラミ
ド及び一般式(2) 【化2】 (式中、R3 は炭素数10〜26の直鎖若しくは分岐鎖
の飽和若しくは不飽和の炭化水素基を示し、R4 は炭素
数9〜25の直鎖若しくは分岐鎖の飽和若しくは不飽和
の炭化水素基を示す)で表わされるセラミドの類似構造
物質からなる群より選ばれる一種又は二種以上 (B)一般式(3) R5-(OCH2CH2)n-OH (3) 〔式中、R5 はコレステロール類の水酸基プロトンを除
く残基又は次式(4) 【化3】 (式中、R6 は炭素数10〜26の直鎖又は分岐鎖のア
ルキレン基を示し、R7及びR8 はそれぞれポリオキシ
エチレンが付加していてもよい炭素数10〜26の直鎖
又は分岐鎖のアルキル基を示す)で表わされる基を示
し、nは5≦n<40の整数を示す〕で表わされる化合
物を含有する皮膚外用剤。1. The following components (A) and (B): (A) General formula (1) (In the formula, R 1 and R 2 represent a linear or branched saturated or unsaturated hydrocarbon group having 8 to 26 carbon atoms in which one or more hydroxyl groups may be substituted) and general ceramides Formula (2) (In the formula, R 3 represents a linear or branched saturated or unsaturated hydrocarbon group having 10 to 26 carbon atoms, and R 4 represents a linear or branched saturated or unsaturated hydrocarbon group having 9 to 25 carbon atoms. A hydrocarbon group) or one or more selected from the group consisting of ceramide-like structural substances (B) General formula (3) R 5- (OCH 2 CH 2 ) n -OH (3) [Formula In the formula, R 5 is a residue excluding the hydroxyl group proton of cholesterol or the following formula (4): (In the formula, R 6 represents a linear or branched alkylene group having 10 to 26 carbon atoms, and R 7 and R 8 each represent a linear or branched C 10 to 26 carbon atom to which polyoxyethylene may be added. Represents a group represented by a branched chain alkyl group), and n represents an integer of 5 ≦ n <40].
5:5〜5:95である請求項1記載の皮膚外用剤。2. The weight ratio of component (A) to component (B) is 9
The external preparation for skin according to claim 1, which is 5: 5 to 5:95.
は2記載の皮膚外用剤。3. The external preparation for skin according to claim 1, further comprising glycerin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18023493A JP3522794B2 (en) | 1993-07-21 | 1993-07-21 | External preparation for skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18023493A JP3522794B2 (en) | 1993-07-21 | 1993-07-21 | External preparation for skin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0733633A true JPH0733633A (en) | 1995-02-03 |
JP3522794B2 JP3522794B2 (en) | 2004-04-26 |
Family
ID=16079723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP18023493A Expired - Lifetime JP3522794B2 (en) | 1993-07-21 | 1993-07-21 | External preparation for skin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3522794B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08245337A (en) * | 1995-02-15 | 1996-09-24 | L'oreal Sa | Cosmetic composition containing ceramides and method for use of it |
JP2004175670A (en) * | 2002-11-22 | 2004-06-24 | Kao Corp | Oil-in-water type emulsified cosmetic |
JP2006248925A (en) * | 2005-03-08 | 2006-09-21 | Kose Corp | Pearl agent composition and cosmetic containing the same |
-
1993
- 1993-07-21 JP JP18023493A patent/JP3522794B2/en not_active Expired - Lifetime
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08245337A (en) * | 1995-02-15 | 1996-09-24 | L'oreal Sa | Cosmetic composition containing ceramides and method for use of it |
JP2922150B2 (en) * | 1995-02-15 | 1999-07-19 | ロレアル | Cosmetic composition containing ceramides and method of using the same |
JP2004175670A (en) * | 2002-11-22 | 2004-06-24 | Kao Corp | Oil-in-water type emulsified cosmetic |
JP2006248925A (en) * | 2005-03-08 | 2006-09-21 | Kose Corp | Pearl agent composition and cosmetic containing the same |
Also Published As
Publication number | Publication date |
---|---|
JP3522794B2 (en) | 2004-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0459285B2 (en) | ||
JP2540296B2 (en) | Cosmetics | |
CN110882174A (en) | Moisturizing emulsion and preparation method thereof | |
JP2004307491A (en) | Skin care preparation for external use containing heparinoid | |
JP3503834B2 (en) | Cosmetics | |
JP3522794B2 (en) | External preparation for skin | |
JPH0686373B2 (en) | Cosmetics | |
JP2641003B2 (en) | External preparation for skin | |
JPS62120308A (en) | Cosmetic | |
JP2005289995A (en) | Oil/water type cosmetic composition manufactured using polyglyceryl-3-methylglucose distearate | |
JP2001010946A (en) | Skin cosmetic | |
JPS60184005A (en) | Cosmetic for preventing aging of skin | |
JPH0616533A (en) | Make-up goods composition | |
JP2741143B2 (en) | External preparation for skin | |
JPS6127908A (en) | Preventive for chapping | |
JP3220294B2 (en) | Skin protection composition | |
JPS617205A (en) | Cell activator | |
JP3195397B2 (en) | Water-in-oil emulsion cosmetics | |
JPH06287106A (en) | Skin cosmetic | |
JP3660374B2 (en) | Topical skin preparation | |
JP2791145B2 (en) | Skin cosmetics | |
JP2995014B2 (en) | Skin cosmetics | |
JP3010028B2 (en) | Skin cosmetics | |
JPH0692298B2 (en) | External skin preparation | |
JPS62192307A (en) | Skin cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20040108 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Effective date: 20040203 Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040205 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 4 Free format text: PAYMENT UNTIL: 20080220 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090220 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100220 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 6 Free format text: PAYMENT UNTIL: 20100220 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 7 Free format text: PAYMENT UNTIL: 20110220 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120220 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120220 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130220 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 10 Free format text: PAYMENT UNTIL: 20140220 |
|
EXPY | Cancellation because of completion of term |